Abstract:An estimated 160 million people world‐wide are exposed to levels of arsenic in their drinking water higher than the limit of 10 ppb (10 μg/L) set by the World Health Organization. Arsenic is a Group 1 (proven) human carcinogen which causes skin, lung, and bladder tumors, and is associated with numerous other adverse health effects, including neuropathy and cardiovascular dysfunctions. Multidrug resistance proteins (MRPs/ABCCs) mediate the cellular efflux of a chemically diverse array of endogenous and xenobiotic metabolites. Substrates include glutathione (GSH) conjugates of inorganic and methylated arsenic species and dimethylarsinic acid (DMA V ). Unlike in humans, arsenic is a poor carcinogen in rodents, requiring at least 100‐fold higher doses for tumour induction. Differences in toxicokinetics between humans and other species are also well documented. We have shown that human MRP4 (hMRP4) reduces the cytotoxicity and cellular accumulation of inorganic and methylated arsenic species, and hMRP4‐enriched membrane vesicle transport studies identified the GSH conjugate of the highly toxic methylated arsenic metabolite monomethylarsonous acid (MMA III ), MMA(GS) 2 , and the major human urinary metabolite DMA V as the transported forms. The objective of the current study was to determine if mouse Mrp4 (mMrp4) conferred resistance to and/or transported the same arsenic species as hMRP4. HEK293 clonal cell lines stably expressing mMrp4 were established and used in cytotoxicity assays. Our results showed that mMrp4 did not confer resistance to any of the arsenic species tested [arsenite (As III ), arsenate (As V ), MMA III , monomethylarsonic acid (MMA V ), dimethylarsinous acid (DMA III ) or DMA V ]. Studies with mMrp4‐enriched membrane vesicles showed that unlike hMRP4, mMrp4 did not transport MMA(GS) 2 or DMA V . Thus, under the conditions tested, arsenicals are not substrates for mMrp4. These results suggest that hMRP4/mMrp4 could contribute to differences in arsenic toxicokinetics between humans and mice. Furthermore, Mrp4/Abcc4(−/−) mice are unlikely to be a relevant model for understanding the in vivo contribution of hMRP4 to arsenic detoxification and elimination. Support or Funding Information Canadian Institutes of Health Research, Alberta Innovates Health Solutions, Faculty of Medicine and Dentistry, University of Alberta

Differential Specificity of the Human and Mouse Multidrug Resistance Protein 4 (MRP4) Orthologs for Arsenic Metabolites